Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cloarec

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Epidemiology and Infection|April 1, 1993
Bacterial load of cockroaches in relation to urban environmentC Rivault, A Cloarec, A Le Guyader
European Journal of Pharmacology|September 15, 1995
In vivo pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonistM Cazes, D Provost, A Versigny, et al.
Epidemiology and Infection|December 1, 1992
Cockroaches as carriers of bacteria in multi-family dwellingsA Cloarec, C Rivault, F Fontaine, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1991
Pharmacological profile of UP 5145-52, an original antiulcer and antisecretory agentC Dedieu-Chaufour, F Hertz, F Caussade, et al.
Journal of Medicinal Chemistry|January 1, 1986
[p-[(Thienylcarbonyl)amino]phenoxy]propanolamines derivatives as diuretic and beta-adrenergic receptor blocking agentsE Bouley, J M Teulon, M Cazes, et al.
International Journal of Immunopharmacology|January 1, 1989
Modulation of immune responses in mice by oral administration of niflumic acidI Florentin, J Maral, M de Sousa, et al.
Journal of Medicinal Chemistry|November 13, 1992
Cardiotonic agents. Synthesis and cardiovascular properties of novel 2-arylbenzimidazoles and azabenzimidazolesT Güngör, A Fouquet, J M Teulon, et al.
Fundamental & Clinical Pharmacology|January 1, 1995
In vitro pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonistF Caussade, A Virone-Oddos, C Delchambre, et al.
British Journal of Pharmacology|February 1, 1997
In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferationA Virone-Oddos, V Desangle, D Provost, et al.
American Journal of Hypertension|March 1, 1997
Effects of UP269-6, a new angiotensin II receptor antagonist, and captopril on the progression of rat diabetic nephropathyE Villa, A Rábano, M Cazes, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Epidemiology and Infection|April 1, 1993
Bacterial load of cockroaches in relation to urban environmentC Rivault, A Cloarec, A Le Guyader
European Journal of Pharmacology|September 15, 1995
In vivo pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonistM Cazes, D Provost, A Versigny, et al.
Epidemiology and Infection|December 1, 1992
Cockroaches as carriers of bacteria in multi-family dwellingsA Cloarec, C Rivault, F Fontaine, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1991
Pharmacological profile of UP 5145-52, an original antiulcer and antisecretory agentC Dedieu-Chaufour, F Hertz, F Caussade, et al.
Journal of Medicinal Chemistry|January 1, 1986
[p-[(Thienylcarbonyl)amino]phenoxy]propanolamines derivatives as diuretic and beta-adrenergic receptor blocking agentsE Bouley, J M Teulon, M Cazes, et al.
International Journal of Immunopharmacology|January 1, 1989
Modulation of immune responses in mice by oral administration of niflumic acidI Florentin, J Maral, M de Sousa, et al.
Journal of Medicinal Chemistry|November 13, 1992
Cardiotonic agents. Synthesis and cardiovascular properties of novel 2-arylbenzimidazoles and azabenzimidazolesT Güngör, A Fouquet, J M Teulon, et al.
Fundamental & Clinical Pharmacology|January 1, 1995
In vitro pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonistF Caussade, A Virone-Oddos, C Delchambre, et al.
British Journal of Pharmacology|February 1, 1997
In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferationA Virone-Oddos, V Desangle, D Provost, et al.
American Journal of Hypertension|March 1, 1997
Effects of UP269-6, a new angiotensin II receptor antagonist, and captopril on the progression of rat diabetic nephropathyE Villa, A Rábano, M Cazes, et al.
Pageof 4